Delivery Order SPE2DB22D1002-SPE2DB24FLDC1

Award Date 6/5/24
Potential Completion Date 6/27/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 200-unit vials of Botox to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, with a ceiling value of $6,985.56. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $3,492.78 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract has a ceiling value of $61,123.65 and a completion date of May 9, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a single-award IDC with the DLA Troop Support Medical...
This federal contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,055.45 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the supply of BOTOX 200 UNIT VIALS to the U.S. Department of Defense (DoD), specifically the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,910.65, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, with an ultimate completion date of December 4, 2024. The contract was not set aside for any specific business category....
This federal contract award is for the delivery of Botox 200 unit vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,463.90 and is a firm fixed-price delivery order. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical,...
This federal contract award, valued at $14,553.25, was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA). The contract is for the delivery of 200-unit vials of Botox, a prescription pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award is for the supply of BOTOX 100 UNIT VIALS, with a ceiling value of $10,336.32. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLDC1
    Delivery Order

This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis with a ceiling value of $11,642.60. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which has a maximum value of $999,999,999.00 and provides the company with a primary vehicle to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a leading supplier of pharmaceuticals and medical products to the federal government, Amerisourcebergen leverages its extensive supply chain and distribution capabilities to efficiently fulfill critical medical supply requirements for the DoD and other government agencies.

Generated 9/4/24, 9:35 AM